The results demonstrated that the LNCaP human prostate cancer cells that were transfected with pcDNA3.1(+) plasmid-mediated pcDNA3.1(+)-EphA2, markedly enhanced the cell growth and invasion <i>in vitro</i>. This evidence concerns the gene EPHA2 and prostate cancer.